Mesoblast (MESO) Revenue (2014 - 2023)
Mesoblast (MESO) posted quarterly Revenue of $1.9 million for Q2 2023, down 16.59% year-on-year from $2.2 million in Q2 2022, and down 4.33% on a QoQ basis from $1.9 million in Q1 2023.
Mesoblast (MESO) Revenue (2014 - 2023) Analysis & Trends
Mesoblast (MESO) has reported Revenue for 10 consecutive years, with $1.9 million the latest figure, recorded in Q2 2023.
- Quarterly Revenue fell 16.59% year-over-year to $1.9 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $8.1 million (down 20.07% YoY) and the FY2025 annual result came in at $17.2 million, up 191.39% from the prior year.
- Revenue declined to $1.9 million in Q2 2023 per MESO's latest filing, from $1.9 million in the prior quarter.
- Over the last five years, Revenue for MESO reached as high as $26.6 million in Q2 2020 and fell as low as $1.0 million in Q1 2019.
- A 5-year average of $3.5 million and a median of $2.0 million in 2020 frame the typical range for Revenue.
- Annual changes were most pronounced in 2020 — Revenue soared 1251.14% — and 2021, when it slumped 87.69%.
- Year by year, Revenue stood at $2.0 million in 2019, then rose by 13.81% to $2.2 million in 2020, then surged by 57.79% to $3.5 million in 2021, then sank by 39.65% to $2.1 million in 2022, then retreated by 13.07% to $1.9 million in 2023.
- According to Business Quant data, Revenue over the past three periods registered $1.9 million, $1.9 million, and $2.1 million for Q2 2023, Q1 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 1.94 Mn |
| Dec 31, 2022 | 2.13 Mn |
| Sep 30, 2022 | 2.22 Mn |
| Jun 30, 2022 | 2.22 Mn |
| Mar 31, 2022 | 2.01 Mn |
| Dec 31, 2021 | 3.54 Mn |
| Sep 30, 2021 | 2.42 Mn |
| Jun 30, 2021 | 3.27 Mn |
| Mar 31, 2021 | 1.96 Mn |
| Dec 31, 2020 | 2.24 Mn |
| Sep 30, 2020 | 1.31 Mn |
| Jun 30, 2020 | 26.58 Mn |
| Mar 31, 2020 | 2.08 Mn |
| Dec 31, 2019 | 1.97 Mn |
| Sep 30, 2019 | 1.87 Mn |
| Jun 30, 2019 | 1.97 Mn |
| Mar 31, 2019 | 1.04 Mn |
| Dec 31, 2018 | 1.22 Mn |
| Sep 30, 2018 | 1.10 Mn |